MNKD stock forecast
Our latest prediction for Mannkind Corp's stock price was made on the Jan. 31, 2022 when the stock price was at 3.73$.
In the short term (2weeks), MNKD's stock price should underperform the market by -0.43%. During that period the price should oscillate between -10.60% and +12.65%.
In the medium term (3months), MNKD's stock price should underperform the market by -4.81%. During that period the price should oscillate between -36.93% and +34.48%.
Get email alertsCreate a solid portfolio with MNKD
About Mannkind Corp
mannkind corporation (nasdaq: mnkd) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. in addition, mannkind is applying our novel technologies and services to support partner development efforts.
At the moment the company generates 75M USD in revenues.
On its last earning announcement, the company reported a loss of -0.32$ per share.
The book value per share is -1.35$
Three months stock forecastJan. 31, 2022
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
75M | 48.50% | -53M | -70.90% | -81M | -0.32 | - | - | 249M | -1.35 | -62M | -11M | -73M |